Key result
AI-based noninvasive tests for MASLD screening offer potential utility despite notable methodological and practical pitfalls.
Key points are not available for this paper at this time.
Jerome Boursier, Bertrand Cariou; Non-invasive tests developed using artificial intelligence for screening in MASLD: interest and pitfalls, The Journal of
No takes yet. Share an insight, caveat, or question.
Boursier et al. (2025) studied this question. Artificial intelligence-based noninvasive tests for MASLD screening offer potential clinical utility but are accompanied by notable methodological and practical pitfalls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: